Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Completed
- Conditions
- Kidney Cancer
- First Posted Date
- 2012-03-02
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01542333
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
Completed
- Conditions
- B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic Leukemia
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2012-02-29
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 70
- Registration Number
- NCT01540578
- Locations
- ๐บ๐ธ
Children's Oncology Group, Monrovia, California, United States
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2012-02-15
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 12
- Registration Number
- NCT01533168
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
Completed
- Conditions
- Adrenocortical Carcinoma
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 10
- Registration Number
- NCT01528956
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
Completed
- Conditions
- LymphomaLeukemia
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01520246
Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma
Completed
- Conditions
- Neuroblastoma
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 100
- Registration Number
- NCT01520233
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder
Completed
- Conditions
- Leukemia
- First Posted Date
- 2012-01-18
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 60
- Registration Number
- NCT01511575
Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
Completed
- Conditions
- Neuroblastoma
- First Posted Date
- 2012-01-16
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 99
- Registration Number
- NCT01510600
Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial
Completed
- Conditions
- Leukemia
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 10
- Registration Number
- NCT01507441
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Phase 3
Completed
- Conditions
- Fungal InfectionHematopoietic and Lymphoid Cell Neoplasm
- Interventions
- First Posted Date
- 2012-01-04
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 292
- Registration Number
- NCT01503515
- Locations
- ๐บ๐ธ
Phoenix Childrens Hospital, Phoenix, Arizona, United States
๐บ๐ธLoma Linda University Medical Center, Loma Linda, California, United States
๐บ๐ธChildren's Hospital and Research Center at Oakland, Oakland, California, United States